This news could not be more timely, as Alzheimer’s Disease has become the sixth leading cause of death in the US, and one which has increased by 68 percent between 2000-2010 [TTA 25 March]. The National Institutes on Health (NIH) with the National Institute on Aging and 27 private sector companies and non-profits has started the second phase of the Alzheimer’s Disease Neuroimaging Initiative (ADNI II). It will continue to track the ADNI subjects from the study that ended in 2010, and enroll additional normal, mildly cognitively impaired, and Alzheimer’s disease patients. Additional plans for ADNI II include PET imaging scans on every new patient enrolled. Foundation for the National Institutes on Health.